127 related articles for article (PubMed ID: 11218406)
21. Impact of Helicobacter pylori antimicrobial resistance on the outcome of 1-week lansoprazole-based triple therapy.
Huang AH; Sheu BS; Yang HB; Huang CC; Wu JJ; Lin XZ
J Formos Med Assoc; 2000 Sep; 99(9):704-9. PubMed ID: 11000734
[TBL] [Abstract][Full Text] [Related]
22. [Progress of tailor-made treatment of peptic ulcer].
Aoyama N; Shirasaka D; Okumura K
Nihon Rinsho; 2002 Jan; 60(1):174-81. PubMed ID: 11808330
[TBL] [Abstract][Full Text] [Related]
23. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
[TBL] [Abstract][Full Text] [Related]
24. Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens.
Giannini E; Romagnoli P; Fasoli A; Chiarbonello B; Malfatti F; Botta F; Risso D; Lantieri PB; Savarino V; Testa R
Am J Gastroenterol; 2000 Oct; 95(10):2762-7. PubMed ID: 11051345
[TBL] [Abstract][Full Text] [Related]
25. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
Ushiama H; Echizen H; Nachi S; Ohnishi A
Clin Pharmacol Ther; 2002 Jul; 72(1):33-43. PubMed ID: 12152002
[TBL] [Abstract][Full Text] [Related]
26. [Helicobacter pylori eradication therapy for children].
Konno M
Nihon Rinsho; 2005 Nov; 63 Suppl 11():470-3. PubMed ID: 16363581
[No Abstract] [Full Text] [Related]
27. Efficacy of a triple therapy with rabeprazole, amoxicillin, and faropenem as second-line treatment after failure of initial Helicobacter pylori eradication therapy.
Togawa J; Inamori M; Fujisawa N; Takahashi H; Yoneda M; Kawamura H; Abe Y; Kirikoshi H; Kobayashi N; Sakaguchi T; Takamura T; Nakajima A; Ueno N; Sekihara H
Hepatogastroenterology; 2005; 52(62):645-8. PubMed ID: 15816496
[TBL] [Abstract][Full Text] [Related]
28. Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.
Uygun A; Kadayifçi A; Yeşilova Z; Savaş MC; Ateş Y; Karslioğlu Y; Ciğerim M; Bağci S; Dağalp K
Turk J Gastroenterol; 2004 Dec; 15(4):219-24. PubMed ID: 16249974
[TBL] [Abstract][Full Text] [Related]
29. [Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?].
Nagahara A; Sato N
Nihon Rinsho; 2005 Nov; 63 Suppl 11():421-5. PubMed ID: 16363572
[No Abstract] [Full Text] [Related]
30. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T
Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
[TBL] [Abstract][Full Text] [Related]
31. Sufficient effect of 1-week omeprazole and amoxicillin dual treatment for Helicobacter pylori eradication in cytochrome P450 2C19 poor metabolizers.
Aoyama N; Tanigawara Y; Kita T; Sakai T; Shirakawa K; Shirasaka D; Kodama F; Okumura K; Kasuga M
J Gastroenterol; 1999; 34 Suppl 11():80-3. PubMed ID: 10616772
[TBL] [Abstract][Full Text] [Related]
32. [Triple therapy for eradication of Helicobacter pylori in Japan].
Takeda H
Nihon Rinsho; 2005 Nov; 63 Suppl 11():409-13. PubMed ID: 16363569
[No Abstract] [Full Text] [Related]
33. [Eradication of Helicobacter pylori in patients with end-stage renal disease undergoing dialysis treatment].
Tsukada K; Katoh H; Miyazaki T; Kuwano H
Nihon Rinsho; 2005 Nov; 63 Suppl 11():486-8. PubMed ID: 16363585
[No Abstract] [Full Text] [Related]
34. [H. pylori eradication package set (Lansap)].
Kawai T; Kawakami K; Moriyasu F; Takagi Y
Nihon Rinsho; 2005 Nov; 63 Suppl 11():361-5. PubMed ID: 16363560
[No Abstract] [Full Text] [Related]
35. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.
Shimoyama T; Fukuda S; Mikami T; Fukushi M; Munakata A
J Gastroenterol; 2004 Oct; 39(10):927-30. PubMed ID: 15549444
[TBL] [Abstract][Full Text] [Related]
36. Influence of CYP2C19 functional polymorphism on Helicobacter pylori eradication.
Ozdil B; Akkiz H; Bayram S; Bekar A; Akgöllü E; Sandikçi M
Turk J Gastroenterol; 2010 Mar; 21(1):23-8. PubMed ID: 20533108
[TBL] [Abstract][Full Text] [Related]
37. [Cause and prevention of nocturnal gastric acid breakthrough].
Adachi K; Kinoshita Y
Nihon Rinsho; 2002 Feb; 60 Suppl 2():779-83. PubMed ID: 11979888
[No Abstract] [Full Text] [Related]
38. Improvements in Helicobacter pylori eradication rates through clinical CYP2C19 genotyping.
Tamura T; Kurata M; Inoue S; Kondo T; Goto Y; Kamiya Y; Kawai S; Hamajima N
Nagoya J Med Sci; 2011 Feb; 73(1-2):25-31. PubMed ID: 21614934
[TBL] [Abstract][Full Text] [Related]
39. Dual therapy using a double dose of lansoprazole with amoxicillin versus triple therapy using a double dose of lansoprazole, amoxicillin, and clarithromycin to eradicate Helicobacter pylori infection: results of a prospective randomized open study.
Lamouliatte H; Cayla R; Zerbib F; Forestier S; de Mascarel A; Joubert-Collin M; Mégraud F
Am J Gastroenterol; 1998 Sep; 93(9):1531-4. PubMed ID: 9732938
[TBL] [Abstract][Full Text] [Related]
40. Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen.
Nagahara A; Miwa H; Kawabe M; Kurosawa A; Asaoka D; Hojo M; Iijima K; Terai T; Ohkusa T; Miyazaki A; Sato N
J Gastroenterol; 2004 Nov; 39(11):1051-5. PubMed ID: 15580397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
